eToroTrade IPO stocks the day they listStart on eToro
All companies
SC

Scribe Therapeutics Inc

SCTX
PublicArchived
Public / ArchivedUnited StatesUSUnited States(NASDAQ-GM)Best valuation $542.77M1 market

Public listing

Listed· NASDAQ-GM· Listing market: United StatesUS United States
Listing date
Not available
Offer price
Not available
Shares offered
Not available
Offering proceeds
$128.7M

Sources: sec-harvest, nasdaq

IPO Calendar
IPO Calendar · NASDAQ-GMIPO
SCTX
Price
$28.67
24h
-6.95%
Valuation
$542.77M
24h volume
$4.25M
Type
IPO
IPO CalendarTrade Scribe Therapeutics Inc

Now trading publicly. Buy via a broker — opens in a new tab.

IPO Calendar · updated 2h ago

SEC IPO filings

Final prospectus

EDGAR filings resolved from SCTX / CIK 0001853921.

424B4424B4
Jul 27, 2026Final prospectus0001193125-26-316503
FWPFWP
Jul 24, 2026Free writing prospectus0001193125-26-314757
8-A12B8-A12B
Jul 21, 2026Exchange registration0001193125-26-309199
S-1/AS-1/A
Jul 20, 2026Amended0001193125-26-308330
S-1/AS-1/A
Jul 10, 2026Amended0001193125-26-300994
S-1S-1
Jul 2, 2026Filed0001193125-26-294804
Jun 12, 2026Confidential draft0001193125-26-269670
Mar 6, 2026Confidential draft0001193125-26-096844
Jan 9, 2026Confidential draft0001193125-26-009106

Scribe Therapeutics Inc IPO — frequently asked questions

When did Scribe Therapeutics Inc go public?
Scribe Therapeutics Inc has already gone public and now trades publicly on NASDAQ-GM under the ticker SCTX.
Can I buy Scribe Therapeutics Inc stock?
Yes — Scribe Therapeutics Inc is publicly traded on NASDAQ-GM as SCTX. You can follow its live price, valuation and post-IPO performance above.
What is Scribe Therapeutics Inc's valuation?
Scribe Therapeutics Inc's most recent valuation tracked here is $542.77M, derived from live market prices.